focus -WSS

focus

author：hotspot 2025-08-12 09:09:07 - browse：99

Light hits on the portrait of George Washington on a one dollar bill. The portrait is surrounded by white and red tablets coming out of a pill bottle, as well as some coins — coverage from STAT — Adobe

WASHINGTON — Pharmaceutical companies are doing anything they can to stop President Biden’s Medicare program from being able to negotiate prices for their products, including suing the government. Experts say their efforts might actually benefit Biden by reminding voters that he’s taking on big drug companies.

When Democrats passed a law directing Medicare to negotiate drug prices, it was considered a major achievement. The new law, two decades in the making, gives Biden an accomplishment to both tout for himself and criticize Republicans for opposing — no Republicans voted to let Medicare negotiate drug prices.

Medicare price negotiation is popular with voters, as are the law’s price-inflation limits, and it includes additional, direct benefits for older adults that are easy to understand. It caps annual out-of-pocket retail-drug spending for seniors and people with disabilities, and it caps their monthly spending on insulin at $35.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Prescription digital therapeutics are key to pharma’s future

WSS

Micronoma's microbiome cancer diagnostic approach under fire

Top Ukrainian generals say counteroffensive is 'going to plan' as losses mount

Canadians with cystic fibrosis outlive Americans by a decade

Use doctors trained outside the U.S. to ease the physician shortage

Trump’s hydroxychloroquine hype: a risk to my treatment and to him

National panel will explore requiring free Covid tests

Wikipedia

focus

explore

Hepatitis C has a cure — but many Americans still lack access to it

Wildfire pollution widens asthma inequities on Long Island

United colonoscopy coverage change 'may cost lives,' doctors say

What to expect as Trump is arraigned on his Jan 6. indictment

State Dept. review finds Biden bears some blame for Afghanistan failures

What affirmative action's end means to a medical student

Dobbs anniversary: the lost opportunity of abortion as health care

Drug cartel violence flares in western Mexico after vigilante leader's killing

Walensky prepares to leave CDC — and Congress — behind

Canadian Prime Minister Justin Trudeau separating from wife, Sophie

Wikipedia

Prescription digital therapeutics are key to pharma’s future

Undocumented workers face uncertainty as immigration law takes effect in Florida

Trump’s hydroxychloroquine hype: a risk to my treatment and to him

Dexcom's push to bring CGM to type 2 diabetes patients

Micronoma's microbiome cancer diagnostic approach under fire

Hubble vs. James Webb telescope images: See the difference

focus

focus

knowledge

hotspot